DAPERNO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 631
EU - Europa 253
AS - Asia 147
AF - Africa 7
OC - Oceania 2
SA - Sud America 2
Totale 1.042
Nazione #
US - Stati Uniti d'America 625
IT - Italia 95
SG - Singapore 48
IE - Irlanda 46
CN - Cina 43
SE - Svezia 30
FI - Finlandia 21
GB - Regno Unito 14
IN - India 13
UA - Ucraina 10
FR - Francia 9
HK - Hong Kong 9
VN - Vietnam 9
ID - Indonesia 8
NL - Olanda 8
CA - Canada 6
DE - Germania 6
KR - Corea 5
EG - Egitto 4
IR - Iran 3
JP - Giappone 3
PH - Filippine 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
DK - Danimarca 2
EE - Estonia 2
ES - Italia 2
NG - Nigeria 2
PL - Polonia 2
TH - Thailandia 2
AT - Austria 1
CH - Svizzera 1
GR - Grecia 1
RU - Federazione Russa 1
SN - Senegal 1
TW - Taiwan 1
Totale 1.042
Città #
Chandler 121
Ann Arbor 100
Santa Clara 80
Dublin 46
Singapore 38
Fairfield 29
Beijing 21
Ashburn 15
Houston 12
Lappeenranta 12
Nyköping 12
Torino 12
Columbus 10
Seattle 10
Milan 9
Princeton 9
Turin 9
Jakarta 8
Medford 8
Dong Ket 7
Jacksonville 7
Woodbridge 7
Cambridge 6
Hong Kong 6
Dearborn 5
Helsinki 5
New Delhi 5
Ottawa 5
Pisa 5
Redwood City 5
Villeurbanne 5
Appiano Gentile 4
Boston 4
Guangzhou 4
Nijmegen 4
Phoenix 4
Wilmington 4
Boardman 3
Padova 3
Selvazzano Dentro 3
Seoul 3
Abuja 2
Albany 2
Alexandria 2
Amsterdam 2
Baltimore 2
Brussels 2
Changchun 2
Chiang Mai 2
Council Bluffs 2
Gurgaon 2
Hangzhou 2
Hefei 2
London 2
Nanjing 2
New York 2
Nuremberg 2
Odense 2
Pinagbuhatan 2
Rome 2
Sale 2
San Diego 2
San Giorgio di Piano 2
Sterling 2
Tallinn 2
Warsaw 2
Washington 2
Wuhan 2
Acqui Terme 1
Athens 1
Atlanta 1
Barzago 1
Birmingham 1
Bronx 1
Cagliari 1
Cairo 1
Cartura 1
Central District 1
Chengdu 1
Cleveland 1
Collegeville 1
Como 1
Dalian 1
Delhi 1
Düsseldorf 1
Edinburgh 1
Fremont 1
Fuzhou 1
Garden City 1
Godalming 1
Grugliasco 1
Haikou 1
Harbin 1
Hebei 1
Jasaan 1
Jouy-le-moutier 1
Kunming 1
Lausanne 1
Mashtul as Suq 1
Melbourne 1
Totale 751
Nome #
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 160
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study 143
Mo1920 – Results of Interim Analysis of a Retrospective Igibd Study on Adalimumab Use in Real Practice in Italy: the Real-Life Clinical Effectiveness of Adalimumab in Ulcerative Colitis (REALADA-UC) Study 138
Application of multiple laboratory tests for Mycobacterium avium ssp. paratuberculosis detection in Crohn's disease patient specimens [*V. Allizond is the corresponding author] 129
P. 06.1 RELATIONSHIP BETWEEN NOD2/CARD15 GENE POLYMORPHISMS AND RESPONSE TO ANTI-TNF AGENTS IN INFLAMMATORY BOWEL DISEASES: RESULTS OF A CLINICAL COHORT STUDY 101
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 87
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 78
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 72
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 59
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy 52
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 33
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 25
Totale 1.077
Categoria #
all - tutte 3.818
article - articoli 0
book - libri 0
conference - conferenze 423
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 6 6 2 1 6 2 11
2020/2021132 6 8 7 5 30 12 3 11 6 17 10 17
2021/2022199 2 1 3 6 13 20 36 32 25 16 28 17
2022/2023318 33 33 9 22 38 58 17 25 54 5 14 10
2023/2024119 18 17 8 9 6 8 6 11 1 22 3 10
2024/2025188 3 27 15 24 98 21 0 0 0 0 0 0
Totale 1.077